CARDIOPROTECTIVE EFFECT OF TUMOR NECROSIS FACTOR ALPHA ANTAGONIST IN DOXORUBICIN MYOCARD TOXICITY
Doxorubicin (Dox) is a first line drug in neoplasia treatment. It is however cardiotoxic even in moderate dosages. High mortality of oncological patients from cardiomyopathic heart failure on Dox treament is a serious problem of oncology and cardiology. Among the cardiotoxicity factors of Dox are ac...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2018-02-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/687 |